• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 7-11, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 7-11, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/8/11Washington, DCWilliam Slikker, Jr.N/AKeynote address at the Society of Toxicology’s 50th Annual Meeting
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/10/11Silver Spring, MDLawrence Deyton, Michael R. Taylor, Luciana Borio, Michele Mital, Larry Bachorik, Joseph Reardon John Auerbach, Clayton Earl Hunter, Paul Halverson, Mary Selecky, Jose Montero (Association of State and Territorial Health Officials [ASTHO])Food Safety, Menu Labeling, Implementation of the Family Smoking Prevention and Tobacco Control Act and Shelf-life Extension of Medical Countermeasures
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine3/8/11Washington, DCN/AN/AUnited States Animal Health Association and American Association of Veterinary Laboratory Diagnosticians Annual Committee on Government Relations Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/8/11Silver Spring, MDRalph Tyler, David Roeder, Donald Beers, Peter Beckman, Luciana Borio, Martha MonserSeveral representatives from Gates Foundation, Bio Ventures Global Health, Allow Ventures, Merck and Co., Novartis, iOne World Health and TB AlliancesPriority Review Voucher (PRV) 
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/10/11Washington, DCJanet Woodcock,  Lawrence J. Lesko, Julie ZawiszaSeveral representatives from private industry and pharmaceutical companiesSpeech at rEVOLUTION 2011- The Sixth Annual Symposium for Chief Scientific Officers Focused on Drug R&D Issues
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition3/10/11College Park, MDLinda Katz, Mitch Cheeseman, Andrew Zajac, Tracey SandersStuart Pope (Patton Boggs, LLP); Mel Drozen (Keller and Heckman); Peter Hutt (Covington and Burling, LLP); Sten Rizk, Doreothy Lagg (Mars Incorporated)Color Additive Approval Process
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition3/11/11College Park, MDBerhane Girmay, Judith Kraus, Grace KimDavid Rosenthal, Audrae Erickson (Corn Refiners Association); Clausen Ely (Covington and  Burling, LLP)High Fructose Corn Sugar Co-labeling
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs3/8/11Silver Spring, MDN/AVincent Ahonkhai (Gates Foundation)International Issues
Beth Martino, Associate Commissioner for External Affairs3/7/11Silver Spring, MDMeghan ScottDavid Carter, Kelly Dencker, Kevin Lamb (Coyne Public Relations)Media and Social Media Metrics
Beth Martino, Associate Commissioner for External Affairs3/9/11Silver Spring, MDMeghan Scott, Heidi Rebello, Michael HerndonFelice Freyer, Kathryn Foxhall (Association of Health Care Journalists)FDA Media Policy
Beth Martino, Associate Commissioner for External Affairs3/9/11Silver Spring, MDMeghan ScottBill Beaman (OnPoint Strategies)Writing
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research3/7/11-3/11/11N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/10/11Bethesda, MDShaAvhree Buckman, George Rochester, Stephen Wilson, Robert TempleAndreas Bruckner (Bayer- Schering Pharma); Harry Seifert (GlaxoSmithKline Biologicals); Steve Snapinn (Amgen, Inc.); Kay Dickersin (John Hopkins University)DIA/FDA Best Practices for Regulatory Information Synthesis of Randomized Controlled Trials for Product Safety Evaluation
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/10/11Rockville, MDDavid Jacobson-Kram, Donna MendrickChristopher Austin (National Institute of Health)Tox 21 General Meeting